##gff-version 3
##sequence-region O75030 1 526
O75030	UniProtKB	Chain	1	526	.	.	.	ID=PRO_0000127276;Note=Microphthalmia-associated transcription factor	
O75030	UniProtKB	Domain	311	364	.	.	.	Note=bHLH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00981	
O75030	UniProtKB	Region	224	295	.	.	.	Note=Transactivation	
O75030	UniProtKB	Region	374	395	.	.	.	Note=Leucine-zipper;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24631970;Dbxref=PMID:24631970	
O75030	UniProtKB	Region	401	431	.	.	.	Note=DNA binding regulation	
O75030	UniProtKB	Coiled coil	355	402	.	.	.	Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24631970;Dbxref=PMID:24631970	
O75030	UniProtKB	Modified residue	180	180	.	.	.	Note=Phosphoserine%3B by MAPK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673502;Dbxref=PMID:10673502	
O75030	UniProtKB	Modified residue	405	405	.	.	.	Note=Phosphoserine%3B by GSK3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587587;Dbxref=PMID:10587587	
O75030	UniProtKB	Modified residue	414	414	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18220336,PMID:18669648,PMID:23186163	
O75030	UniProtKB	Modified residue	491	491	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
O75030	UniProtKB	Modified residue	516	516	.	.	.	Note=Phosphoserine%3B by RPS6KA1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673502;Dbxref=PMID:10673502	
O75030	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15507434;Dbxref=PMID:15507434	
O75030	UniProtKB	Cross-link	423	423	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15507434;Dbxref=PMID:15507434	
O75030	UniProtKB	Alternative sequence	1	118	.	.	.	ID=VSP_002127;Note=In isoform M1%2C isoform M2 and isoform Mdel. MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKSSSSAEHPGASKPPISSSSMTSRILLRQQLMREQMQEQERREQQQKLQAAQFMQQRVPVSQTPAINVSVPTTLPSATQVPMEVLK->MLEMLEYNHYQ;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:20163701,ECO:0000303|PubMed:8069297;Dbxref=PMID:15489334,PMID:20163701,PMID:8069297	
O75030	UniProtKB	Alternative sequence	1	52	.	.	.	ID=VSP_046438;Note=In isoform 12. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O75030	UniProtKB	Alternative sequence	1	35	.	.	.	ID=VSP_002126;Note=In isoform H1 and isoform H2. MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKSS->MEALRVQMFMPCSFESLYL;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O75030	UniProtKB	Alternative sequence	1	34	.	.	.	ID=VSP_002124;Note=In isoform B1 and isoform B2. MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKS->MLYAFWFSH;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O75030	UniProtKB	Alternative sequence	1	34	.	.	.	ID=VSP_002125;Note=In isoform C1 and isoform C2. MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKS->MGHLENTSVVFPRAIFSLCEKETRKLTLCLFSR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O75030	UniProtKB	Alternative sequence	139	194	.	.	.	ID=VSP_045178;Note=In isoform Mdel. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:20163701;Dbxref=PMID:20163701	
O75030	UniProtKB	Alternative sequence	293	298	.	.	.	ID=VSP_045179;Note=In isoform Mdel and isoform 12. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:20163701;Dbxref=PMID:14702039,PMID:20163701	
O75030	UniProtKB	Alternative sequence	294	299	.	.	.	ID=VSP_002128;Note=In isoform A2%2C isoform B2%2C isoform C2%2C isoform H2 and isoform M2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11230166,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9647758;Dbxref=PMID:11230166,PMID:15489334,PMID:9647758	
O75030	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_078311;Note=In WS2A%3B unknown pathological significance. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28236341;Dbxref=PMID:28236341	
O75030	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_010297;Note=In WS2A%3B unknown pathological significance. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8589691;Dbxref=PMID:8589691	
O75030	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_077922;Note=In COMMAD%3B has both cytoplasmic and nuclear localization%3B decreased binding to M-box or E-box DNA sequences. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27889061;Dbxref=dbSNP:rs1057519325,PMID:27889061	
O75030	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_010298;Note=In TADS. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10851256;Dbxref=dbSNP:rs104893745,PMID:10851256	
O75030	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_077923;Note=In COMMAD. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27889061;Dbxref=dbSNP:rs1057519326,PMID:27889061	
O75030	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_010299;Note=In WS2A and COMMAD%3B does not localize to the nucleus%3B does not bind M-box or E-box DNA sequences%3B loss of function in transcriptional regulation%3B dominant negative effect. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:27889061,ECO:0000269|PubMed:8589691;Dbxref=PMID:27889061,PMID:8589691	
O75030	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_010300;Note=In WS2A. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8589691;Dbxref=dbSNP:rs104893744,PMID:8589691	
O75030	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_010301;Note=In WS2A. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8589691;Dbxref=PMID:8589691	
O75030	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_010302;Note=In WS2A. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8589691;Dbxref=dbSNP:rs104893747,PMID:8589691	
O75030	UniProtKB	Natural variant	425	425	.	.	.	ID=VAR_067367;Note=In CMM8%3B associated with disease susceptibility%3B also associated with pheochromocytomas and paragangliomas susceptibility%3B results in impaired sumoylation. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22012259,ECO:0000269|PubMed:22080950,ECO:0000269|PubMed:27680874;Dbxref=dbSNP:rs149617956,PMID:22012259,PMID:22080950,PMID:27680874	
O75030	UniProtKB	Mutagenesis	180	180	.	.	.	Note=Abolishes both transcription factor activity and ubiquitination%2C leading to an inert and stable protein%3B when associated with A-516. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673502;Dbxref=PMID:10673502	
O75030	UniProtKB	Mutagenesis	289	289	.	.	.	Note=Loss of sumoylation%3B when associated with R-423. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15507434;Dbxref=PMID:15507434	
O75030	UniProtKB	Mutagenesis	405	405	.	.	.	Note=Loss of phosphorylation and function. S->A%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587587;Dbxref=PMID:10587587	
O75030	UniProtKB	Mutagenesis	423	423	.	.	.	Note=Loss of sumoylation%3B when associated with R-289. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15507434;Dbxref=PMID:15507434	
O75030	UniProtKB	Mutagenesis	516	516	.	.	.	Note=Abolishes both transcription factor activity and ubiquitination%2C leading to an inert and stable protein%3B when associated with A-180. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673502;Dbxref=PMID:10673502	
O75030	UniProtKB	Sequence conflict	241	241	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O75030	UniProtKB	Helix	357	401	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4C7N	
